Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Song JS"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-5 z 5
    Tytuł:
    Combined Hepatocellular-Cholangiocarcinoma With Ductal Plate Malformation Pattern: A Case Report With Molecular Analysis.
    Autorzy:
    Moon WS; Departments of Pathology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea.
    Song JS; Departments of Radiology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea.
    Yu HC; Departments of Surgery, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea.
    Kim KM; Departments of Pathology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea.
    Ahn AR; Departments of Pathology, Jeonbuk National University Medical School, Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, and Research Institute for Endocrine Sciences, Jeonju, Jeonbuk, Republic of Korea.
    Pokaż więcej
    Źródło:
    International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 160-164. Date of Electronic Publication: 2023 May 01.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Carcinoma, Hepatocellular*/diagnosis
    Carcinoma, Hepatocellular*/genetics
    Carcinoma, Hepatocellular*/surgery
    Liver Neoplasms*/diagnosis
    Liver Neoplasms*/genetics
    Liver Neoplasms*/pathology
    Cholangiocarcinoma*/genetics
    Cholangiocarcinoma*/surgery
    Cholangiocarcinoma*/pathology
    Bile Duct Neoplasms*/genetics
    Bile Duct Neoplasms*/surgery
    Bile Duct Neoplasms*/pathology
    Male ; Humans ; Middle Aged ; Bile Ducts, Intrahepatic/pathology ; p120 GTPase Activating Protein
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Medical expenditure for liver cancer in urban China: A 10-year multicenter retrospective survey (2002-2011).
    Autorzy:
    Qiu WQ; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, P. R. China.
    Shi JF; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Guo LW; Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, Henan, P. R. China.
    Mao AY; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, P. R. China.
    Huang HY; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Hu GY; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, P. R. China.
    Dong P; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, P. R. China.
    Bai FZ; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Yan XL; Public Health Information Research Office, Institute of Medical Information, Chinese Academy of Medical Sciences, Beijing, P. R. China.
    Liao XZ; Department of Human Resources, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China.
    Liu GX; Department of Health Economics, School of Health Management, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
    Bai YN; Institute of Epidemiology and Health Statistics, Lanzhou University, Lanzhou, Gansu, P. R. China.
    Ren JS; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Sun XJ; Center for Health Management and Policy, Key Lab of Health Economics and Policy, Shandong University, Jinan, Shandong, P. R. China.
    Zhu XY; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Zhou JY; Center for Health Management and Policy, Key Lab of Health Economics and Policy, Shandong University, Jinan, Shandong, P. R. China.
    Gong JY; Science and Education Department of Public Health Division, Shandong Tumor Hospital, Jinan, Shandong, P. R. China.
    Zhu L; Teaching and Research Department, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P. R. China.
    Mai L; Department of Cancer Epidemiology, Henan Office for Cancer Control and Research, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou, Henan, P. R. China.
    Du LB; Zhejiang Office for Cancer Control and Research, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, P. R. China.
    Zhou Q; Chongqing Office for Cancer Control and Research, Chongqing Cancer Hospital, Chongqing, P. R. China.
    Xing XJ; Liaoning Office for Cancer Control and Research, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, P. R. China.
    Song BB; Heilongjiang Office for Cancer Control and Research, Affiliated Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.
    Liu YQ; Cancer Epidemiology Research Center, Gansu Provincial Cancer Hospital, Lanzhou, Gansu, P. R. China.
    Lou PA; Department of Control and Prevention of Chronic Non-Communicable Diseases, Xuzhou Center for Disease Control and Prevention, Xuzhou 221006, Jiangsu, P. R. China.
    Sun XH; Ningbo Clinical Cancer Prevention Guidance Center, Ningbo No. 2 Hospital, Ningbo, Zhejiang, P. R.C Shandong, P. R. China.
    Wu SL; Health Department of Kailuan Group, Kailuan General Hospital, Tangshan, Hebei, P. R. China.
    Cao R; Department of Health Policy and Economic Research, Guangdong Provincial Institute of Public Health, Guangzhou, Guangdong, P. R. China.
    Qi X; Department of Occupational Medicine, Tangshan People's Hospital, Tangshan, Hebei, P. R. China.
    Lan L; Institute of Chronic Disease Prevention and Control, Harbin Center for Disease Control and Prevention, Harbin, Heilongjiang, P. R. China.
    Ren Y; Urban Office of Cancer Early Detection and Treatment, Tieling Central Hospital, Tieling, Liaoning, P. R. China.
    Zhang K; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    He J; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Qu C; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Dai M; Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, National Cancer Center of China, No. 17 Panjiayuannanli, Chaoyang District, Beijing, P. R. China.
    Pokaż więcej
    Źródło:
    Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Jan; Vol. 14 (1), pp. 163-170.
    Typ publikacji:
    Journal Article; Multicenter Study
    MeSH Terms:
    Urban Population*
    Health Expenditures/*statistics & numerical data
    Liver Neoplasms/*epidemiology
    Adult ; Aged ; Aged, 80 and over ; China/epidemiology ; Costs and Cost Analysis ; Female ; Humans ; Liver Neoplasms/diagnosis ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Public Health Surveillance ; Retrospective Studies ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Regulatory T cells, especially ICOS regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival.
    Autorzy:
    Tu JF; Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Ding YH; Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou 310000, Zhejiang Province, China.
    Ying XH; Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Wu FZ; Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Zhou XM; Department of Pathology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Zhang DK; Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Zou H; Department of Cardiology, Zhejiang Provincial People's Hospital, Hangzhou 310000, Zhejiang Province, China.
    Ji JS; Department of Radiology and Interventional Radiology, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2016 Oct 11; Vol. 6, pp. 35056. Date of Electronic Publication: 2016 Oct 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Hepatocellular/*pathology
    Forkhead Transcription Factors/*metabolism
    Inducible T-Cell Co-Stimulator Protein/*metabolism
    Liver Neoplasms/*pathology
    T-Lymphocytes, Regulatory/*immunology
    Adult ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/metabolism ; Carcinoma, Hepatocellular/immunology ; Female ; Humans ; Liver Neoplasms/immunology ; Lymphocytes, Tumor-Infiltrating ; Male ; Middle Aged ; Prognosis ; Random Allocation ; Survival Analysis ; Tumor Microenvironment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Laparoscopic Radiofrequency Ablation for Large Subcapsular Hepatic Hemangiomas: Technical and Clinical Outcomes.
    Autorzy:
    Gao J; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China.
    Ji JS; Department of Radiology, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical College, Zhejiang, 32300, China.
    Ding XM; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China.
    Ke S; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China.
    Xin ZH; Department of General Surgery, Zhanhua People's Hospital, Shandong 256800, China.
    Ning CM; Department of General Surgery, Chaoyang Central Hospital, Liaoning 122000, China.
    Guo SG; Department of General Surgery, Chaoyang Central Hospital, Liaoning 122000, China.
    Li XL; Department of General Surgery, Affiliated Hospital of Chifeng University, Neimenggu 024000, China.
    Dong YH; Department of General Surgery, Shanxi Provincial People's Hospital, Shanxi 032200, China.
    Sun WB; Department of Hepatobiliary Surgery, Beijing Chao-yang Hospital Affiliated with Capital Medical University, No. 5 Jingyuan Street, Beijing 100043, China.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2016 Feb 22; Vol. 11 (2), pp. e0149755. Date of Electronic Publication: 2016 Feb 22 (Print Publication: 2016).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Catheter Ablation*
    Laparoscopy*
    Hemangioma/*surgery
    Liver Neoplasms/*surgery
    Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    International trends in primary liver cancer incidence from 1973 to 2007.
    Autorzy:
    Zhang Y; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .
    Ren JS; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .
    Shi JF; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .
    Li N; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .
    Wang YT; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China. .
    Qu C; State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing, 100021, China. .
    Zhang Y; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .; Yale School of Public Health, Yale School of Medicine, Yale Cancer Center, New Haven, CT, 06510, USA. .
    Dai M; National Office for Cancer Prevention and Control, Cancer Institute & Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, 100021, China. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2015 Mar 04; Vol. 15, pp. 94. Date of Electronic Publication: 2015 Mar 04.
    Typ publikacji:
    Historical Article; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Liver Neoplasms/*epidemiology
    Age Factors ; Datasets as Topic ; Female ; Global Health ; History, 20th Century ; History, 21st Century ; Humans ; Incidence ; Liver Neoplasms/history ; Male ; Population Surveillance ; Sex Factors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-5 z 5

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies